We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Study Finds Myocarditis Caused by Infection Rising Globally

By Michal Siman-Tov
Posted on 07 Dec 2016
Print article
Image: A new study assessing the global state of myocarditis examines diagnostics, treatments, and causes. The results suggest that even though diagnosis is difficult, early diagnosis is key to preventing long-term heart damage from the disease (Photo courtesy of the Mayo Clinic).
Image: A new study assessing the global state of myocarditis examines diagnostics, treatments, and causes. The results suggest that even though diagnosis is difficult, early diagnosis is key to preventing long-term heart damage from the disease (Photo courtesy of the Mayo Clinic).
A new assessment of the global state of myocarditis examines diagnostics, treatments, and causes, the most common cause being viral infections.

Myocarditis, an assortment of heart disorders often caused by infection and inflammation, is difficult to diagnose and treat. Dilated cardiomyopathy and cardiac sarcoidosis can result from myocarditis. Among the young, myocarditis accounts for about 5% of sudden cardiovascular infant deaths and up to 20% of sudden cardiovascular death in adolescents. It is responsible for up to 45% of heart transplants in the US.

The new global assessment was conducted by a team led by Leslie Cooper Jr, MD, cardiologist, at the Mayo Clinic (Jacksonville, FL, USA). Along with Dr. Cooper, researchers from the Netherlands, Switzerland, and Finland contributed to the study.

Dr. Cooper and colleagues recently reported that cases of myocarditis have increased from about 1.5 million annually to 2.2 million cases from 2013 to 2015. The new study found that the rate of myocarditis and associated death is much higher in men than in women, likely due to testosterone-driven inflammation.

The most common cause of myocarditis is infection ― usually viral ― that can damage heart muscle chronically or acutely in otherwise healthy people, said Dr. Cooper. Infections that affect the heart differ around the globe. In the US, a dozen common pathogens can be responsible. An example is coxsackie virus, which up to 70% of US residents have been exposed to age 30. “But only 1-2% of people with acute coxsackie virus infection develop cardiac symptoms,” said Dr. Cooper.

Myocarditis can also have other causes, including autoimmune diseases, environmental toxins, and adverse reactions to medications.

Early diagnosis is key to preventing long-term heart damage from myocarditis. If chronic disease results, scarring in the heart can promote heart failure. Although standard therapies are used to control symptoms of heart failure, new investigational therapies based on mechanistic advances may soon enter clinical trials, and new management of the disorder is being discussed. “We are on a quest for advances in treating this disorder,” said Dr. Cooper.

To prevent the disorder from worsening in children, Dr. Cooper suggests that aerobic exercise be limited for several weeks after a suspected coxsackie virus infection, and “if a child or adolescent develops breathing difficulties or chest pain with evidence of myocarditis, my recommendation is to avoid competitive sports for at least 3 months,” said Dr. Cooper.

Revised management recommendations regarding athletic participation after acute myocarditis have further heightened the importance of early diagnosis. A cardiac MRI within 2 weeks of symptom onset is 80% effective in diagnosing cardiomyopathy, but diagnosis is difficult at more chronic stages. The sensitivity of endomyocardial biopsy may be increased, especially in suspected sarcoidosis, by the use of electrogram guidance to target regions of abnormal signal.

Most people (60-70%) with acute cardiomyopathy from myocarditis get better. About 10-15% develop irreversible chronic disease due to scars in the heart created by infection. These patients are treated with standard heart failure therapies, but 20% die during the decade following infection due to heart failure. “I see patients everyday with this disorder,” said Dr. Cooper, “We are on the cusp of trying more tailored treatment, and it can’t come soon enough.”

The study, by Heymans S et al, was published November 29, 2016, in the Journal of the American College of Cardiology.

Related Links:
Mayo Clinic

Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
HDL Subfractions Kit
Lipoprint HDL Subfractions Kit
Semi-Automatic Coagulation Analyzer
Clot 2B
Silver Supplier
HSV1+2 / VZV Test
Savvygen HSV1+2 / VZV

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group plc (London, UK), a life sciences company developing oncology drugs and diagnostics, has acquired Coris Bioconcept SRL (Gembloux, Belgium) for an upfront cash consideration of GBP 7.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.